Literature DB >> 26870263

Clinicopathological features of dermatofibrosarcoma protuberans.

Noppadol Larbcharoensub1, Jitchai Kayankarnnavee1, Suda Sanpaphant1, Kidakorn Kiranantawat2, Chewarat Wirojtananugoon3, Vorachai Sirikulchayanonta1.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a superficial cutaneous tumor of low malignant potential characterized by a high rate of local recurrence. The histopathological appearance shows uniform spindle neoplastic cells arranged in a predominantly storiform pattern, typically with positive staining for cluster of differentiation (CD)34 and vimentin on immunohistochemistry. A minority of cases of DFSP have areas of sarcomatous transformation. Wide surgical excision is the cornerstone of treatment for DFSP. The objective of the present study was to determine the clinicopathological features of DFSP. Pathological records were searched for cases of DFSP in the database of the Department of Pathology, Faculty of Medicine Ramathibodi Hospital (Mahidol University, Bangkok, Thailand) between 1994 and 2013. The results showed 68 cases with DFSP. The mean age at diagnosis was 40 years (range, 3-86 years). Among this group of patients, 26 cases (38.2%) experienced local recurrence and 6 (8.8%) exhibited sarcomatous transformation of DFSP. The factors that predict the recurrence of DFSP are an incorrect first pathological diagnosis and an inadequate surgical margin. The factors that predict the sarcomatous transformation of DFSP are a larger tumor size and an incorrect first pathological diagnosis. In patients who have tumors with spindle cells arranged in a storiform pattern, CD34 immunohistochemical staining provides the definitive diagnosis. Exact histopathological categorization is important to select the appropriate treatment and predict the clinical outcome.

Entities:  

Keywords:  aggressive cutaneous tumor; dermatofibrosarcoma protuberans; recurrence; sarcomatous transformation

Year:  2015        PMID: 26870263      PMCID: PMC4726970          DOI: 10.3892/ol.2015.3966

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.

Authors:  J R Goldblum; J D Reith; S W Weiss
Journal:  Am J Surg Pathol       Date:  2000-08       Impact factor: 6.394

2.  The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.

Authors:  Jared J Abbott; Andre M Oliveira; Antonio G Nascimento
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

3.  Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.

Authors:  Ozlem Erdem; Angela J Wyatt; E Lin; Xuemei Wang; Victor G Prieto
Journal:  Am J Dermatopathol       Date:  2012-02       Impact factor: 1.533

Review 4.  Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review.

Authors:  Maria Archontaki; Dimitris P Korkolis; Niki Arnogiannaki; Charikleia Konstantinidou; Spyros Georgopoulos; Panagiotis Dendrinos; Georgios Zarkadas; Georgios Kokkalis
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

Review 5.  Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.

Authors:  Marco Fiore; Rosalba Miceli; Chiara Mussi; Salvatore Lo Vullo; Luigi Mariani; Laura Lozza; Paola Collini; Patrizia Olmi; Paolo G Casali; Alessandro Gronchi
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

6.  Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression.

Authors:  N Sato; K Kimura; Y Tomita
Journal:  J Dermatol       Date:  1995-09       Impact factor: 4.005

Review 7.  Dermatofibrosarcoma protuberans: recent clinical progress.

Authors:  Grant McArthur
Journal:  Ann Surg Oncol       Date:  2007-07-24       Impact factor: 5.344

8.  Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas.

Authors:  J H Connelly; H L Evans
Journal:  Am J Surg Pathol       Date:  1992-10       Impact factor: 6.394

9.  CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.

Authors:  V G Prieto; J A Reed; C R Shea
Journal:  J Cutan Pathol       Date:  1994-08       Impact factor: 1.587

10.  Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.

Authors:  Derek DuBay; Vincent Cimmino; Lori Lowe; Timothy M Johnson; Vernon K Sondak
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  6 in total

1.  [Alternative therapy option for plastic-aesthetic treatment of defects after resection in the upper third of the facial region in the sense of subtotal scalping instead of local flap plastics].

Authors:  F J Kupilas; J Kleinheinz
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

2.  Dermatofibrosarcoma protuberance in a black African cohort-a clinicopathologic study.

Authors:  Gabriel Olabiyi Ogun; Uchenna Simon Ezenkwa; Omobolaji Oladayo Ayandipo
Journal:  Ecancermedicalscience       Date:  2020-08-07

Review 3.  The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.

Authors:  Malumani Malan; Wu Xuejingzi; Song Ji Quan
Journal:  Pan Afr Med J       Date:  2019-08-13

4.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

5.  Massive Facial Presentation of Dermatofibrosarcoma Protuberans.

Authors:  Sebastiaan Hermans; Karlijn Clarysse; David Emmanuel Las; Johan de Mey; Maurice Yves Mommaerts; Yannick De Brucker
Journal:  Case Rep Radiol       Date:  2022-04-30

6.  Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review.

Authors:  Jian-Xia Xiong; Tao Cai; Li Hu; Xiao-Li Chen; Kun Huang; Ai-Jun Chen; Ping Wang
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.